Skip to main content
Caplight Logo









ExoHeal

ExoHeal

Private
GermanyHealthcare & Life Scienceshttps://exoheal.co

Last Round

Accelerator

Apr 1, 2026

Total Funding Raised

$128,000

Company Overview

ExoHeal operates in Healthcare & Life Sciences and is based in Germany. Its latest recorded funding round was an Accelerator round in April 2026.

ExoHeal is a med-tech company that develops an AI-driven exoskeletal glove for hand paralysis rehabilitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

ExoHeal Comparables

Compare ExoHeal with similar companies based on industry and business-model similarity.

ExoHeal comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Emovo Care
88%
Zunosaki Limited
85%
Motus Nova
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

ExoHeal Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 1, 2026
GrantMay 24, 2022
GrantApr 17, 2020
GrantNov 27, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ramin Udash

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

ExoHeal Investors

Notable investors and investment history

ExoHeal investors
InvestorRounds
hessian.AIAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 484% MoM, reaching 5.8K.

  • Apr 20, 2026

    Monthly visitors increased 464% MoM, reaching 998.

Book a demo to see all signals

For institutional investors. Book with your work email.

ExoHeal Filings

Explore SEC and related filing metadata, where available.

ExoHeal filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about ExoHeal's valuation, stock price, and market status.

Is ExoHeal a public or private company?

ExoHeal is a private company.

What is the current stock price of ExoHeal?

ExoHeal is a private company, so its shares have no public market price. Caplight tracks ExoHeal's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ExoHeal worth (valuation)?

Valuation information for ExoHeal is not publicly available.

Can I buy ExoHeal stock?

ExoHeal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ExoHeal's last funding round?

ExoHeal's most recent funding round was Accelerator on April 1, 2026.

Who are the main investors in ExoHeal?

Key investors in ExoHeal include hessian.AI.

Will ExoHeal IPO soon?

No public IPO plans have been announced for ExoHeal.

How can I track ExoHeal secondary market activity?

Caplight tracks bids, offers, and trades in ExoHeal's shares on secondary markets.

Firmographic Details

HeadquartersGermany
Employee Range3
Year Founded2016
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?